Concepedia

Katharina Prochazka

KP

Statistics

Publications

8

Citations

273

H-Index

8

Active since

2016

Affiliations

Medical University of Graz(Current)

Paracelsus Medical University

The University of Texas MD Anderson Cancer Center

BioTechMed-Graz

University Hospital Ulm

Katharina Prochazka is an author at Medical University of Graz specializing in oncology, molecular oncology, and medicine.

ORCID

Publications per year

2016–2023

8

Publications

8

Clinical implications of subclonal <i>TP53</i> mutations in acute myeloid leukemia

Katharina Prochazka, Gudrun Pregartner, Frank G. Rücker et al. · Haematologica · 2018 · 97 citations · Full text

, , +17

NCCN-IPI score-independent prognostic potential of pretreatment uric acid levels for clinical outcome of diffuse large B-cell lymphoma patients

Katharina Prochazka, Thomas Melchardt, Florian Posch et al. · British Journal of Cancer · 2016 · 45 citations · Full text

, , +13

NR4A3 Suppresses Lymphomagenesis through Induction of Proapoptotic Genes

Alexander Deutsch, Beate Rinner, Martin Pichler et al. · Cancer Research · 2017 · 44 citations · Full text

, , +13

Immunohistochemistry for c‐myc and bcl‐2 overexpression improves risk stratification in primary central nervous system lymphoma

Stefan Hatzl, Florian Posch, Alexander Deutsch et al. · Hematological Oncology · 2020 · 28 citations · Full text

, , +17

The CXCR4–CXCL12-Axis Is of Prognostic Relevance in DLBCL and Its Antagonists Exert Pro-Apoptotic Effects In Vitro

Katrin Pansy, Julia Feichtinger, Barbara Ehall et al. · International Journal of Molecular Sciences · 2019 · 23 citations · Full text

, , +14

1–5 of 8